Skip to content

Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model.

Attenni B, Ontoria JM, Cruz JC, Rowley M, Schultz-Fademrecht C, Steinkühler C, Jones P. (2009)
Bioorg Med Chem Lett. 2009 Jun 1;19(11):3081-4.

More info on PubMed.gov

IRBM IN THE NEWS

PRESS RELEASES

EVENTS

Back To Top